Seeking AlphaCodex · 实盘不做把握 5/10
北京时间·🕒 发布 05:35:20时区推断·⟳ 抓取 05:36:22·⚡ 决策 07-23 05:41:35 +5m13s·96.6 天前
Edwards Lifesciences将于7月23日盘后发布二季度业绩，市场预期收入17亿美元
正文仅列示一致预期：EPS 0.74美元同比增长10.4%，收入17亿美元同比增长11.1%。
📄 原文Seeking Alpha↗ 原文
Edwards Lifesciences Q2 2026 Earnings Preview
- Edwards Lifesciences (EW) is scheduled to announce Q2 earnings results on Thursday, July 23rd, after market close. -…
不做 Edwards Lifesciences（EW.US）
仅为业绩预告日历，尚无实际业绩、超预期幅度或指引变化，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-22 · 扩散 medium · price-in 风险 high ↗
关键理由
- 正文仅列示一致预期：EPS 0.74美元同比增长10.4%，收入17亿美元同比增长11.1%。
主要风险
- EPS预期近3个月上修5次、下修13次，方向并不纯粹；实际业绩尚未发布。
原文全文
展开原文 · 494 字
- Edwards Lifesciences (EW) is scheduled to announce Q2 earnings results on Thursday, July 23rd, after market close.
- The consensus EPS estimate is $0.74 (+10.4% Y/Y) and the consensus revenue estimate is $1.7B (+11.1% Y/Y).
- Over the last 2 years, EW has beaten EPS estimates 88% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 5 upward revisions and 13 downward. Revenue estimates have seen 21 upward revisions and 0 downward.
- The consensus EPS estimate is $0.74 (+10.4% Y/Y) and the consensus revenue estimate is $1.7B (+11.1% Y/Y).
- Over the last 2 years, EW has beaten EPS estimates 88% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 5 upward revisions and 13 downward. Revenue estimates have seen 21 upward revisions and 0 downward.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。